Home > Insider Trading > Filing (0001209191-21-006330)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419600	Flexion Therapeutics Inc	FLXN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1806204	Melissa Layman	C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-27	30,000	$0.00	91,000	No	4	A	Direct
Common Stock	Disposition	2021-01-28	2,624	$12.55	88,376	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

On April 1, 2020, the Reporting Person was granted 30,000 restricted stock units. The vesting of the shares under the restricted stock unit award was to be based on the achievement of a specified amount of 2020 revenues from ZILRETTA product sales established at the time of the Compensation Committee's approval of the restricted stock unit award. On January 27, 2021, the Compensation Committee certified the achievement of a specified amount of 2020 revenues from ZILRETTA product sales resulting in the commencement of vesting of 30,000 shares. The Reporting Person previously reported the restricted stock units in Table II of Form 4.
Sale of shares to cover income tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on April 1, 2020.